Prestalia patents expiration

PRESTALIA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6696481 ADHERA Salt of perindopril and pharmaceutical compositions containing it
Apr, 2023

(5 months ago)

US7846961 ADHERA α crystalline form of the arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it
Oct, 2029

(6 years from now)

Prestalia is owned by Adhera.

Prestalia contains Amlodipine Besylate; Perindopril Arginine.

Prestalia has a total of 2 drug patents out of which 1 drug patent has expired.

Expired drug patents of Prestalia are:

  • US6696481

Prestalia was authorised for market use on 21 January, 2015.

Prestalia is available in tablet;oral dosage forms.

Prestalia can be used as treatment of hypertension.

The generics of Prestalia are possible to be released after 05 October, 2029.

Drugs and Companies using AMLODIPINE BESYLATE; PERINDOPRIL ARGININE ingredient

Market Authorisation Date: 21 January, 2015

Treatment: Treatment of hypertension


How can I launch a generic of PRESTALIA before it's drug patent expiration?
More Information on Dosage

PRESTALIA family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic